32. Chronic lymphocytic leukemia patients who develop resistance to Bruton Tyrosine Kinase (BTK) inhibitors demonstrate heterogeneous patterns of clonal evolution

Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Rashmi Kanagal-Shamanna, Preetesh Jain, Keyur Patel, Carlos Bueso-Ramos, Rajyalakshmi Luthra, Mark Routbort, Zeev Estrov, William Wierda, L. Jeffrey Medeiros
Source: Cancer Genetics - Category: Cancer & Oncology Source Type: research